Compare CAKE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | MYGN |
|---|---|---|
| Founded | 1972 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 444.2M |
| IPO Year | 1996 | 1996 |
| Metric | CAKE | MYGN |
|---|---|---|
| Price | $55.74 | $4.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 8 |
| Target Price | ★ $59.47 | $7.64 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.06 | N/A |
| Revenue | ★ $3,751,806,000.00 | $771,400,000.00 |
| Revenue This Year | $6.16 | $6.89 |
| Revenue Next Year | $6.63 | $5.35 |
| P/E Ratio | $18.61 | ★ N/A |
| Revenue Growth | ★ 4.75 | 2.33 |
| 52 Week Low | $43.00 | $3.76 |
| 52 Week High | $69.70 | $8.59 |
| Indicator | CAKE | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 48.27 |
| Support Level | $52.66 | $4.23 |
| Resistance Level | $56.69 | $5.69 |
| Average True Range (ATR) | 2.06 | 0.28 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 48.54 | 55.89 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.